Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.33−0.53 (-7.73%)
Close on Nov 20, 2026Market cap $573.27MP/E –Yield –
Verastem free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Verastem's free cash flow for the twelve months ending Dec 31, 2024 was -$104.80M. For fiscal 2024 it was -$104.80M. The highest annual figure on record is -$10.16M in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$104.80M | – |
| FY2021 | Dec 31, 2021 | -$53.70M | – |
| FY2020 | Dec 31, 2020 | -$33.54M | – |
| FY2019 | Dec 31, 2019 | -$138.53M | – |
| FY2018 | Dec 31, 2018 | -$76.02M | – |
| FY2016 | Dec 31, 2016 | -$29.52M | – |
| FY2015 | Dec 31, 2015 | -$45.77M | – |
| FY2014 | Dec 31, 2014 | -$39.33M | – |
| FY2013 | Dec 31, 2013 | -$26.36M | – |
| FY2012 | Dec 31, 2012 | -$22.91M | – |
| FY2011 | Dec 31, 2011 | -$10.16M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$25.10M | – |
| Q1 FY2024 | Jun 30, 2024 | -$55.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.93M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.83M | -124.2% |
| Q2 FY2021 | Jun 30, 2021 | -$13.42M | – |
| Q1 FY2021 | Mar 31, 2021 | -$19.51M | – |
| Q4 FY2020 | Dec 31, 2020 | -$21.70M | – |
| Q3 FY2020 | Sep 30, 2020 | $44.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$37.22M | – |
| Q4 FY2018 | Dec 31, 2018 | -$19.45M | – |
| Q3 FY2018 | Sep 30, 2018 | -$23.13M | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.89M | – |
| Q1 FY2018 | Mar 31, 2018 | -$22.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.95M | – |
See a number that looks wrong?